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The Center for Epidemiological Studies-Depression (CES-D) scale is a widely used measure of depressive symptoms, but its
psychometric properties have not been adequately evaluated among adults withHIV/AIDS.This study used an item response theory
approach (Rasch analysis) to evaluate the CES-D’s validity and reliability in relation to key demographic and clinical variables in
adults with HIV/AIDS. A convenience sample of 347 adults with HIV/AIDS (231 males, 93 females, and 23 transgenders; age range
22–77 years) completed the CES-D. A Rasch model application was used to analyze the CES-D’s rating scale functioning, internal
scale validity, person-response validity, person-separation validity, internal consistency, differential item functioning (DIF), and
differential test functioning. CES-D scores were generally high and associated with several demographic and clinical variables. The
CES-D distinguished 3 distinct levels of depression and had acceptable internal consistency but lacked unidimensionality, five items
demonstrated poor fit to the model, 15% of the respondents demonstrated poor fit, and eight items demonstrated DIF related to
gender, race, or AIDS diagnosis. Removal of misfitting items resulted in minimal improvement in the CES-D’s substantive and
structural validity. CES-D scores should be interpreted with caution in adults with HIV/AIDS, particularly when comparing scores
across gender and racial groups.
1. Introduction
Depressive symptoms are common among adults living with
HIV or AIDS, with an estimated 20% to 37% having a major
depressive disorder [1, 2]. Depression among adults with
HIV/AIDS has been associated with high risk behaviors [3],
lowmedication adherence [4], poor health outcomes [5], and
reduced quality of life [6, 7]. Accurately and reliably assessing
depressive symptoms is critical to research aimed at under-
standing and treating depression and thereby improving the
quality of life of people living with HIV/AIDS.
Although a clinical interview by a trained professional
is considered the gold standard for determining a diagnosis
of depression based on DSM or ICD criteria, screening
instruments and symptom rating scales are often used for
research purposes [8]. Symptom rating scales have the benefit
of providing a continuous measure of depressive symptom
frequency or severity, and screening instruments include a
cutoff score indicating the need for further evaluation or a
probable diagnosis of depression. Both are typically quick and
easy to self-administer.
Of the many different instruments used to assess depres-
sive symptoms, the Center for Epidemiological Studies-
Depression (CES-D) scale [9] is one of the more common
measures used in HIV/AIDS research [8]. This 20-item self-
report instrument has demonstrated good reliability and
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validity in a variety of populations [10, 11]. Its development
was based on Beck’s four-factor model of depression, which
includes positive affect, negative affect, somatic symptoms
and retarded activity, and interpersonal difficulties. While
many studies have documented this four-factor structure
[12], some research suggests that these factors may vary
across different groups [13], which raises concern about its
generalizability.
Associations between CES-D scores and demographic
factors, such as race/ethnicity [13–15], gender [16], educa-
tion [17], and income [17–20], have been well documented.
However, it is not clear whether these observed differences
reflect true group differences, psychometric variability across
groups, or a combination of both. Recent studies have
begun to address the possibility of racial/ethnic and gender
differences in the psychometric properties of the CES-D [14,
21–27], although, to our knowledge, none have addressed the
influences of education or income, and none have adequately
addressed these issues in the HIV/AIDS population.
For adults with HIV/AIDS, concern has also been raised
about the CES-D’s inclusion of somatic symptoms of depres-
sion, as they may overlap with disease-related symptoms
and inflate depression scores among those with HIV/AIDS
[28]. Others have shown that the somatic symptoms have
little impact on the CES-D’s ability to distinguish depressed
and nondepressed adults with HIV/AIDS or other chronic
conditions [29]. This issue is not limited specifically to HIV
disease but has been debated in relation to other diagnostic
groups as well [30–33].
Questions have also been raised about the validity of the
CES-D’s four positive affect items (felt as good as other people,
hopeful, happy, and enjoyed life), leading some researchers to
suggest excluding these items from the total CES-D score [34,
35]. In an early study of inpatients withHIV/AIDS, two of the
positive affect items (felt as good as other people and hopeful)
were found not to differ between healthy controls and adults
meeting DSM criteria for depression [29]. In the same study,
it was also found that the two interpersonal items (unfriendly
and felt that people did not like me) were unable to distinguish
nondepressed and depressed patients with HIV/AIDS. How
seriously these issues affect the reliability and validity of the
CES-D for adults with HIV/AIDS remains unknown.
The psychometric properties of the CES-D have been sys-
tematically evaluated using both classical test theory (CTT)
and item response theory (IRT) in a variety of populations
[34, 36]. Althoughmany studies have specifically evaluated its
structural validity using exploratory and confirmatory factor
analysis, results have been inconsistent. Furthermore, these
approaches are largely limited to the specific sample and
cannot determine the degree to which items are equivalent
across individuals. IRT approaches, such as Rasch modeling,
have certain advantages over CTT and have been used to
more fully describe the CES-D’s underlying structure, to
identify items with poor fit to the rest of the scale, and
to identify items that perform inconsistently across groups
[30, 37, 38].
Items that fail to perform consistently across groups are
said to demonstrate differential item function (DIF). This
occurs when a specific item is more or less easily endorsed
by certain groups of respondents while controlling for differ-
ences in the underlying construct being measured [39]. In
the case of the CES-D, DIF occurs when respondents who
have the same underlying levels of depression but belong to
different subgroups (e.g., gender, race, or health status) have
different response patterns to a particular item. This occurs
when the location of an item on the depression continuum
varies depending on the respondent’s group membership.
Understanding whether items demonstrate DIF in relation to
demographic and clinical variables is critical to interpreting
the differences in CES-D scores across various groups [40].
Several studies have used CTT approaches to evaluate
the utility of the CES-D for identifying risk of depression
among adults with HIV/AIDS [29, 41], but none have used
Rasch modeling to evaluate aspects of validity and reliability,
including unidimensionality and stability of item function
across groups. Therefore, the purpose of this study was to
evaluate aspects of the CES-D’s validity and reliability using
an application of the Rasch model in a sample of adults
with HIV/AIDS. Results from this study will also determine
whether there is differential item function, or DIF, in relation
to several key demographic and clinical variables. Given that
a 10-item version of the CES-D has also been suggested for
adults with HIV/AIDS [41], we also use the Rasch model
to evaluate the psychometric properties of this version in
our sample. Although this analysis focuses on adults with
HIV/AIDS, the findings may have potential relevance to
other adults with chronic illness.
2. Method
2.1. Participants and Setting. The Symptom and Genetic
Study was a prospective longitudinal study aimed at identi-
fying biomarkers of symptom experience among adults with
HIV/AIDS [48]. The Committee on Human Research at the
University of California, San Francisco (UCSF) approved
the study protocol (#10-01357). Participants were recruited
from April 2005 to December 2007 using flyers posted at
local HIV/AIDS clinics and community sites. Participants
provided written informed consent and signed a Health
Insurance Portability and Accountability Act release for the
use of their protected medical information in research before
participation. Study visits, each lasting approximately one
hour, were conducted at the University of California, San
Francisco, General Clinical Research Center.
Eligible participants were English-speaking adults at least
18 years of age who had been diagnosed with HIV infection
at least 30 days before enrollment. To specifically address
stableHIV/AIDS-related symptom experience, potential par-
ticipants were excluded if they currently used illicit drugs
(as determined by self-report or by positive urine drug
testing prior to the baseline assessment); worked nights (i.e.,
at least four hours between 12 AM and 6 AM); reported
having bipolar disorder, schizophrenia, or dementia; or were
pregnantwithin the prior threemonths. Participants were not
excluded for insomnia but were excluded for other diagnosed
sleep disorders, such as apnea and narcolepsy. Research
staff conducted eligibility screening by interviewing potential
participants in person or by phone.
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2.2. Measures
2.2.1. Demographic, Clinical, and Laboratory Characteristics.
Ademographic questionnairewas used to collect information
about the participant’s age, gender, race/ethnicity, educa-
tion, and income. A prior diagnosis of AIDS and current
medications (including antiretroviral and antidepressants
medications) were obtained by self-report. Urine screening
was used to detect current illicit drug use both prior to
and three days after enrollment. The most recent CD4+ T-
cell count and viral load values were obtained from the
participant’s medical record.
2.2.2. Depressive Symptoms. The Center for Epidemiological
Studies-Depression (CES-D) scale [9] was used to assess
the frequency of depressive symptoms in the previous week.
The CES-D consists of 20 items selected to represent major
symptoms in the clinical syndrome of depression. Total
scores can range from 0 to 60, with scores of 16 and higher
indicating the need for adults to seek clinical evaluation
for major depression. The CES-D’s four subscales and their
range of scores are positive affect (0 to 12), negative affect
(0 to 21), somatic symptoms and retarded activity (0 to 21),
and interpersonal difficulties (0 to 6). The CES-D has well-
established concurrent and construct validity [11, 49–52]. In
this study, Cronbach’s alpha coefficient for the CES-D was
0.88.
2.3. Statistical Analysis. Descriptive statistics were used
to summarize the study sample, and nonparametric tests
(Kruskal-Wallis andMann-Whitney𝑈) were used to compare
the nonnormal distributions of CES-D scores across demo-
graphic and clinical groups. A Rasch, partial-credit model
application was used to analyze the CES-D scores using
Winsteps Rasch analysis software, version 3.69.1.16 [53]. First,
the rating scale properties of the original 20-itemCES-Dwere
evaluated. A stepwise process was then used whereby items
failing to meet standard fit criteria were removed one at a
time. If multiple items failed to meet the criterion for a given
step, the item with the worst misfit was removed and the step
was repeated with the remaining items until all items met
the criterion set. Cronbach’s alpha coefficient was used as a
measure of internal consistency, and principal components
analysis (PCA) was used to assess unidimensionality. The
analytic approach is summarized in Table 1 and has been
previously described [42, 44, 46, 47, 54–56].
3. Results
3.1. Description of Sample. Of the 560 adults who expressed
interest in the study and were screened for eligibility, 116
were not eligible (primarily due to disqualifying psychiatric
diagnosis, 𝑛 = 74) and 94 chose not to enroll (by either
declining to participate or not showing for the first study
visit). Of the 350 adults with HIV/AIDS enrolled in the study,
threewere excluded fromanalysis due tomissingCES-Ddata.
Thirty participants tested positive for illicit drug use at the
second study visit (3 days after enrolling in the study), and
their data were retained in the analysis to evaluate DIF related
to drug use. Demographic and clinical characteristics of the
347 participants included in the final sample are reported in
Table 2. Overall, depressive symptoms were common in this
sample, and significant differences in total CES-D scores were
observed based on the respondent’s gender, education, viral
load, antidepressant use, and current illicit drug use. There
were also significant demographic and clinical differences in
the 4 component scores of the CES-D.
3.2. Rating Scale Functioning. The rating scale used in the
CES-D met the criteria set. The average measures for each
category and thresholds advanced monotonically.
3.3. Internal Scale Validity. Of the original 20 items in the
CES-D, five failed to demonstrate acceptable goodness-of-fit
(see Tables 1 and 3). Through the stepwise process of deleting
items with unacceptable goodness-of-fit, items 4 (felt as good
as others), 8 (hopeful), 11 (restless sleep), 2 (poor appetite), and
16 (enjoyed life) were sequentially omitted. The remaining
15 items all demonstrated acceptable goodness-of-fit (range
of infit MnSq values: 0.65 to 1.30). For subsequent analytic
steps, psychometric properties were evaluated for both the
original 20-item CES-D and a 15-item version omitting the
five misfitting items.
A principal components analysis (PCA) of the residuals,
also performed using Winsteps, indicated that the Rasch
dimension (depressive symptoms) explained only 32.5% of
the variance in the original 20-item CES-D and 37.9% in the
15-itemversion,whichwere both below the criterion of≥50%.
The secondary dimension explained 9.4% and 7.4% of the
variance in the 20-item and 15-item versions, respectively,
both exceeding the set criterion of <5%.
Because these findings failed to support the unidimen-
sionality of the CES-D as a whole, we complemented the
analysis of the entire 20-item scale with a PCA of each of the
four subscales in order to explore whether they demonstrated
higher levels of unidimensionality. Although the variance
explained in the subscales was generally higher than for the
full scale (either the 20-item or 15-item versions), none of
the subscales reached the set criterion of ≥50% explained
variance (see Table 4).
3.4. Person-Response Validity. In this sample, both the origi-
nal 20-item CES-D and the 15-item version had an unaccept-
ably high proportion of misfitting respondents (see Table 1),
with both exceeding the criterion of <5%. The respondents
whodemonstrated a high degree ofmisfitwere less likely to be
male, White, or diagnosed with AIDS but did not differ from
the rest of the sample with respect to any other demographic
or clinical characteristic listed in Table 2.
3.5. Person-Separation Reliability and Internal Consistency.
The 20-item CES-D demonstrated acceptable person-
separation reliability (index = 2.04) according to the set
criterion of >2.0. The 15-item version had slightly lower
person-separation reliability (index = 1.90), which did
not reach the set criterion. Both versions were able to
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Table 2: CES-D scores by demographic and clinical characteristics,𝑀 (SD).
𝑛 Total CES-D scorea Positive affectb Negative affecta Somatic symptomsa Interpersonal difficultya
Full sample 347 17.2 (10.4) 8.2 (3.2) 5.5 (4.6) 6.7 (4.2) 1.2 (1.5)
Age in years
Mean (SD): 45.1 (8.3)
Range: 22–77 years
<45 years 154 18.1 (10.2) 8.0 (3.2) 5.9 (4.6) 6.8 (4.0) 1.4 (1.5)c
≥45 years 193 16.5 (10.5) 8.4 (3.2) 5.1 (4.6) 6.7 (4.3) 1.1 (1.4)c
Gender
Male 231 16.2 (10.3)c 8.4 (3.2) 5.2 (4.4) 6.4 (4.0) 1.1 (1.3)c
Female 93 19.4 (10.7)c 7.8 (3.3) 6.2 (5.1) 7.6 (4.6) 1.4 (1.6)
Transgender 23 18.1 (9.0) 7.7 (2.9) 5.4 (4.2) 6.6 (3.9) 2.0 (1.8)c
Race
Black 140 16.5 (9.6) 8.1 (3.4) 4.8 (4.4)c 6.4 (4.3) 1.4 (1.5)c
White 140 16.7 (10.2) 8.4 (3.1) 5.7 (4.5) 6.5 (3.9) 1.0 (1.2)c
Other 67 19.7 (11.9) 8.0 (3.0) 6.5 (5.0)c 7.8 (4.5) 1.5 (1.7)
Education completed
<High school 56 21.2 (11.4)d 7.6 (3.2) 6.9 (4.9)c 8.1 (4.8) 1.8 (1.8)d
High school 218 16.4 (9.8)d 8.3 (3.2) 5.1 (4.5)c 6.4 (4.0) 1.2 (1.4)d
College 73 16.6 (10.5)d 8.5 (3.2) 5.4 (4.7) 6.8 (3.9) 1.0 (1.3)d
Income ($/month)
<$1,000 246 17.3 (10.4) 8.2 (3.2) 5.5 (4.6) 6.7 (4.3) 1.3 (1.5)
≥$1,000 101 16.9 (10.4) 8.3 (3.3) 5.4 (4.6) 6.8 (3.9) 1.0 (1.4)
CD4+ T-cell count 329e
<200 (cells/mm3) 59 18.4 (11.0) 8.3 (3.0) 5.7 (4.6) 7.3 (4.2) 1.7 (1.7)c
≥200 (cells/mm3) 270 16.8 (10.3) 8.2 (3.3) 5.3 (4.6) 6.5 (4.2) 1.2 (1.5)c
Viral load (copies/mL) 320e
<10,000 253 16.1 (10.1)c 8.4 (3.2) 5.0 (4.4)c 6.3 (4.0)c 1.1 (1.4)c
≥10,000 67 20.0 (11.1)c 7.9 (3.2) 6.7 (4.9)c 7.6 (4.6)c 1.7 (1.7)c
Years since HIV diagnosis
<5 60 17.8 (11.3) 8.0 (3.3) 5.8 (5.3) 6.6 (4.7) 1.3 (1.7)
≥5 287 17.1 (10.2) 8.3 (3.2) 5.4 (4.5) 6.7 (4.1) 1.2 (1.4)
AIDS diagnosis
No 170 17.9 (10.6) 7.9 (3.4) 5.7 (4.8) 6.8 (4.3) 1.3 (1.6)
Yes 177 16.5 (10.2) 8.6 (2.9) 5.2 (4.4) 6.6 (4.0) 1.2 (1.4)
Antiretroviral therapy?
No 102 18.0 (10.6) 8.0 (3.3) 6.1 (4.8) 6.5 (4.3) 1.4 (1.7)
Yes 245 16.9 (10.3) 8.3 (3.2) 5.2 (4.5) 6.8 (4.1) 1.2 (1.3)
Taking antidepressant?
No 209 16.1 (10.0)c 8.2 (3.2) 4.9 (4.4)c 6.3 (4.0)c 1.2 (1.4)
Yes 138 18.8 (10.8)c 8.2 (3.2) 6.3 (4.9)c 7.4 (4.4)c 1.4 (1.6)
Illicit drug test result 346e
Negative 316 16.9 (10.4)c 8.4 (3.2)c 5.4 (4.6) 6.7 (4.2) 1.2 (1.4)c
Positive 30 20.9 (9.0)c 6.7 (3.3)c 6.5 (4.9) 7.3 (4.2) 1.8 (1.7)c
Note. Nonparametric tests (Kruskal-Wallis and Mann-Whitney 𝑈) were used to compare the nonnormal distributions of CES-D scores across demographic
and clinical groups.
aHigher scores indicate fewer and/or less frequent depressive symptoms; total CES-D scores ≥ 16 indicate need to seek clinical evaluation for depression.
bNot reverse coded; higher scores indicate more positive affect.
cDifference between the groups was significant (𝑝 < 0.05).
dAdults who did not complete high school differed from the other two groups (𝑝 < 0.05).
eSmaller sample due to missing laboratory or drug test data.
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Table 3: CES-D items demonstrating poor fit or differential item
function.
Poor item fit DIF
(1) I was bothered by things that usually don’t
bother me.
(2) I did not feel like eating; my appetite was
poor.
X
(3) I felt that I could not shake off the blues
even with help from my family or friends.
(4) I felt I was just as good as other people. X
(5) I had trouble keeping my mind on what I
was doing.
(6) I felt depressed. Race
(7) I felt that everything I did was an effort.
(8) I felt hopeful about the future. X AIDS
(9) I thought my life had been a failure.
(10) I felt fearful.
(11) My sleep was restless. X
(12) I was happy.
(13) I talked less than usual.
(14) I felt lonely.
(15) People were unfriendly. Gender
(16) I enjoyed life. X Race
(17) I had crying spells. Gender
(18) I felt sad. Race
(19) I felt that people dislike me. Race
(20) I could not get going. Race
Note. Italicized items were not biased by misfit or differential item function
(DIF).
Table 4: Variance explained in each CES-D subscale.
Subscale Items included ineach subscale Variance explained
Positive affect 4, 8, 12, 16 44.2%
Negative affect 3, 6, 9, 10, 14, 17, 18 47.6%
Somatic symptoms
and retarded activity 1, 2, 5, 7, 11, 13, 20 37.7%
Interpersonal
difficulties 15, 19 46.2%
distinguish approximately 3 levels of depressive symptom
severity. Cronbach’s alpha coefficients for both the 20- and
15-item versions of the CES-D were acceptable (0.88 for
both versions) and exceeded the set criterion of >0.80. Even
with a 25% reduction of items (5/20), the 15-item version
demonstrated similar reliability coefficients to the 20-item
version.
3.6. Differential Item Functioning (DIF). Finally, we analyzed
the presence of DIF in relation to sociodemographic and
clinical variables. Of the original 20 items, there was sig-
nificant DIF on specific items in relation to gender, race,
antidepressant use, and AIDS diagnosis (see Tables 3 and 5).
For DIF by gender, item 17 (crying) was more easily endorsed
by female and transgender participants compared to male
participants (i.e., females and transgender participants had
higher scores on this item than what would be expected
by the Rasch model, while males had lower scores than
expected), and item 15 (unfriendly) was more easily endorsed
by transgender compared to male participants. For DIF
by race, items 20 (could not get going), 18 (sad), and 6
(depressed) were more easily endorsed by White participants
compared to Black participants, whereas item 19 (felt disliked)
was more easily endorsed by Black participants than White
participants. In addition, item 16 (enjoyed life)wasmore easily
endorsed by White participants than by participants in the
Other race group.
For DIF by antidepressant use, item 20 (could not get
going) was more easily endorsed by those taking an antide-
pressant than by those whowere not. Finally, forDIF byAIDS
diagnosis, item 8 (hopeful) wasmore easily endorsed by those
who had not been diagnosed with AIDS than by those who
had. Somewhat fewer but similar patterns ofDIFwere evident
in the 15-item version of the CES-D (see Table 5). As shown
in Table 3, two of the items with DIF in the original 20-item
scale (items 8 and 16) also demonstrated poor item fit and
were not included in the 15-item version, thus accounting for
some of the DIF differences between the 15-item and 20-item
versions.There was no DIF related to age, education, income,
or illicit drug use in either version.
3.7. Differential Test Functioning. To evaluate the impact of
eliminating the five misfitting items, individual measures
from the original 20-item CES-D and the 15-item version
were compared by calculating the 𝑧-score of the difference
between the scores. As only 6 participants (1.7%) demon-
strated 𝑧-values exceeding ±1.96, we concluded that the 15-
item version generates similar measures to the original CES-
D for the majority of the sample, despite the lack of unidi-
mensionality in both versions. Furthermore, the original 20-
item CES-D and the 15-itemmeasures were highly correlated
(𝑟 = 0.93, 𝑝 < 0.01), exceeding the criterion of >0.80 and
𝑝 < 0.05.
3.8. Evaluation of the 10-Item Version [41]. In our final step,
we also evaluated the 10-item version suggested by Zhang
et al. [41] for use with adults living with HIV/AIDS (see
Table 1). Even though the rating scale met the criteria in
this version and differential test functioning was acceptable,
one item (item #8) demonstrated misfit (10%) to the Rasch
model, and the 10-item version also failed to meet the
criteria for unidimensionality, as only 34.2% of the total
variance in CES-D scores was explained by the first principal
component. In addition, a higher-than-expected proportion
of the sample (11.0%) demonstrated misfitting responses in
this version. Most importantly, the 10-item version was not
able to distinguish the sample into distinct levels of depressive
symptom severity (separation index = 1.42).
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Table 5: Differential item functioning in the original 20-item CES-D and a 15-item version.
Demographic and clinical variables Original 20-item version 15-item version (omitting items 2, 4, 8, 11 & 16)
Gender
(male, female, and transgender)
Item 15: unfriendly
Transgender∗ >male
Item 17: crying
Female, transgender∗ >male
Item 14: lonely
Males > transgender∗
Item 17: crying
Female, transgender∗ >male
Race
(Black, White, and Other)
Item 20: could not get going
White > Black
Item 19: felt disliked
Black >White
Item 18: sad
White > Black
Item 16: enjoyed life
White > Other race
Item 6: depressed
White > Black
Item 20: could not get going
White > Black
Item 19: felt disliked
Black >White
Item 18: sad
White > Black
Item 6: depressed
White > Black
(Item 16 excluded)
Antidepressant use
(No/Yes)
Item 20: could not get going
Yes > No None
AIDS diagnosis
(No/Yes)
Item 8: hopeful
No AIDS > AIDS None (item 8 excluded)
Note. > indicates that the item was more easily endorsed by the first group than the second group. There was no differential item function related to age,
education, income, duration of HIV diagnosis, or illicit drug use.
∗The transgender group was small (𝑛 = 23) and results should thus be interpreted with caution.
4. Discussion
To our knowledge, this is the first psychometric evaluation
of the CES-D using Rasch analysis in a sample of adults
living with HIV/AIDS. The findings of this study indicate
that there may be serious psychometric limitations to using
the CES-D with this population. Five of the original 20 items
demonstrate substantial item misfit to the Rasch model, but
exclusion of these items resulted in little improvement of the
scale’s psychometric properties. In fact, both short forms we
evaluated, one of which excluded all five of the misfitting
items, demonstrated similar psychometric limitations to the
full scale. Nonetheless, we recognize that the CES-D is widely
used and its use will likely continue until an instrument
with more robust psychometric properties is available. While
there are other depression measures currently in use, to our
knowledge, none have demonstrated robust psychometric
properties for assessing depressive symptoms among adults
with HIV/AIDS or other chronic illnesses. Thus, for those
who use the CES-D to assess depressive symptoms among
adults with HIV/AIDS, it is important that its psychometric
limitations be considered, particularly when used in research
settings and when comparing scores across groups, to avoid
drawing invalid conclusions. Furthermore, we recommend
that the 5 misfitting items be interpreted with particular
caution, especially when their responses seem inconsistent
with the rest of the scale, as they may not be measuring the
same construct as other items.
Of the five misfitting items, three were positive affect
items, which have been identified in other studies as being
poorly correlated with the rest of the scale [34, 35] and
not useful for distinguishing depressed and nondepressed
adults with HIV disease [29]. While it is possible that the
positive affect items represent a separate construct, given the
reversed scaling of these items, the possibility of response
bias should also be considered.The other twomisfitting items
(poor appetite and restless sleep) are somatic in nature. These
symptoms are also relatively common among adults with
HIV/AIDS [48] and may be associated with aspects of HIV
disease or chronic illness that are unrelated to depression.
The results of this study raise concerns about the uni-
dimensionality of the construct measured by the CES-D.
Even the subscales representing Beck’s four components of
depression failed to meet the standards of unidimensionality
as defined for our study sample, thereby raising questions
about the measure’s structural validity. Studies in other
populations have also reported a lack of unidimensionality
due to misfitting items, although the issue could generally be
corrected by excluding the misfitting items [24, 30]. These
results suggest that factors other than depressive symptoms
might be influencing CES-D scores in this sample of adults
with HIV/AIDS.
The gender-related DIF identified in this study was
similar to that reported in non-HIV samples, with women
generally being more likely to report crying and Blacks being
more likely than Whites to report feeling disliked and less
likely to report feeling sad or depressed or that they could not
get going, regardless of their underlying level of depression
[21, 27, 57–59]. This study also included a small sample of
transgender adults, and several items (crying, people were
unfriendly, and lonely) demonstrated DIF for this understud-
ied group as well. Two clinical variables, antidepressant use
and AIDS diagnosis, each demonstrated DIF on a single item
in the 20-item CES-D. Somewhat unexpectedly, there was no
DIF related to illicit drug use, despite higher CES-D scores
among those who tested positive for illicit drugs compared to
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those who did not. It may be reassuring to know that drug
use did not compromise the validity of CES-D scores in this
sample, as conducting urine tests is not always feasible.
In light of the number of items with poor fit to the Rasch
model or demonstrating DIF, the appropriateness of the
clinical cutoff warrants further evaluation in this population.
Items that are poorly correlated with the rest of the scale
and items that result in differential responding in various
subgroups may cause scores to vary systematically across
subgroup, and it would be important to determine whether
those differences are clinically meaningful with respect to
clinical diagnosis and whether a higher or lower cutoff may
be appropriate for different subpopulations of adults with
HIV/AIDS. Further research in this area is warranted if the
CES-D is to be used as a valid screening tool for clinical
depression among a diverse population of adults living with
HIV/AIDS.
Although it might be recommended that the five misfit-
ting items identified in this study be omitted from the CES-D
whenused to assess depressive symptoms in adults livingwith
HIV/AIDS, the resulting 15-item version was only slightly
better in terms of unidimensionality, person-response valid-
ity, and DIF and was slightly worse with respect to person-
separation reliability. Therefore, the psychometric properties
of the 15-item version are not sufficiently better than those of
the original CES-D to warrant such a recommendation.
A number of CES-D short forms have already been devel-
oped for use with various populations, either to minimize
participant burden [60, 61] or to eliminate items that discrim-
inate poorly between depressed and nondepression samples
[62]. A 10-item version of the CES-D has been previously
recommended for use among adults with HIV/AIDS [41].
However, to our knowledge, it has only been evaluated in
relation to its sensitivity and specificity to a 20-item CES-
D score ≥16, and aspects of its internal scale validity (item
fit or DIF) were not assessed. Thus, our findings provide
additional evidence of the psychometric properties of this
version of the CES-D in a similar sample of adults with
HIV/AIDS. Even though the 10-item version omits three of
the five misfitting items identified in our current study, as
well as five of the eight items demonstrating DIF, the criteria
for item fit, unidimensionality, and person fit were not met.
Perhaps the most problematic finding was that the 10-item
CES-D version was unable to separate the sample into even
two distinct levels of depressive symptom severity (as would
be indicated if the separation index was at least 1.5 [46]),
as this raises serious concern regarding this short form as a
useful measure of depressive symptoms among adults with
HIV/AIDS.
The findings of this study need to be considered in light
of several limitations. First, information was not available
regarding the participant’s diagnostic status for depression
other than the proxy of taking antidepressant medication,
and therefore, the utility of individual items for distinguishing
depressed from nondepressed respondents in this sample
could not be determined. This study evaluated a number
of demographic and clinical variables but was not large
enough to examine DIF within groups, such as gender with
differential effects by age or racial/ethnic group. Furthermore,
the sample in this study was sociodemographically diverse
but had insufficient numbers of Hispanic/Latino participants
to specifically evaluate DIF for this group. Lastly, most of the
adults in this sample had been diagnosed with HIV for many
years, and therefore, our findings cannot be generalized to
adults who have been newly diagnosed.
5. Conclusions
In conclusion, in our sample of adults living with HIV/AIDS,
the CES-D lacked internal scale validity (i.e., unidimension-
ality), even after excluding items with poor fit to the Rasch
model, and several items demonstrated significant DIF in
relation to gender and race. In light of these issues, CES-D
scores should be interpreted with caution in this and possibly
other chronic illness populations. Further research is needed
to determine appropriate clinical cutoff scores and identify
brief measures of depression with better psychometric prop-
erties.
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